Dr. Scott Campbell is Executive Director and Chief Executive Officer of the Foundation for the National Institutes of Health (FNIH).  Dr. Campbell joined the organization in July 2010, previously serving as National Vice President of Research Programs at the American Diabetes Association (ADA) from 2001-2010. 

Dr. Campbell serves to guide and strengthen the mission of FNIH, while supporting the National Institutes of Health (NIH) through a wide range of initiatives that advance scientific research to improve human health.  Since joining FNIH, Dr. Campbell has worked with the FNIH Board of Directors and senior  leadership to develop a three year comprehensive strategic plan that will further enhance the foundation’s goals and initiatives.  Supporting the NIH mission and aligning with the current NIH priorities, the plan establishes the FNIH priorities and direction for the coming years, including a focus on programs in the areas of global health, translational research, and research education and training.

Prior to the ADA, Dr. Campbell spent 12 years in academia at the Michael Reese Hospital in Chicago, the University of Missouri and the University of South Dakota.  His primary area of research interest was hypertension, heart failure and the renin-angiotensin system.   Dr. Campbell holds a Ph.D. in Basic Biomedical Sciences from the University of South Florida.  He has authored numerous peer-reviewed articles, reviews and book chapters.

Dr. Campbell has served on numerous external panels/committees including the Board of Trustees for the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), the Institute of Medicine’s Clinical Research Roundtable, and the Board of Directors for the Health Research Alliance (HRA) where he was also Treasurer for the HRA. He is a current member of the Forum on Drug Discovery, Development, and Translation for the Institute of Medicine at the National Academies.

About FNIH

FNIH supports the mission of the National Institutes of Health through a wide range of initiatives that advance scientific biomedical research through public-private, collaborative partnerships.  Having raised more than a half a billion dollars in support of NIH research, the FNIH is a leader in identifying and addressing complex scientific and health issues, leveraging the diverse strengths of stakeholders in the science and research community, industry, academia, advocacy groups, non-governmental organizations, foundations and philanthropy in order to improve human health.